Top 30 Biotech Angel Investors in Singapore (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Tak Wai Chung
Angel
|
2 | Singapore | Seed, Angel | Food Processing, Waste Management | |
|
Paul Buchheit
Angel
|
2 | United States, Canada, India | Seed, Series A, Angel | Software, Artificial Intelligence, E-Commerce | $100k–$14M |
|
Te Ling Nai
Angel
|
2 | Singapore | Seed, Angel | Food Processing, Waste Management | |
|
Frederik Vandermarlie
Angel
|
1 | Belgium, Singapore | Seed | Medical, Legal Tech, Health Care | $2.3M–$4M |
|
Gireesh Narsimhan
Angel
|
1 | Singapore | Seed | Health Care, Biotechnology, Health Diagnostics | |
|
John Ballantyne
Angel
|
1 | United States, Singapore | Seed, Series A, Angel | Health Care, Biotechnology, Therapeutics | $4.5M–$30M |
|
Wendou Niu
Angel
|
1 | Singapore | Series A | Life Science, Biotechnology | |
|
Raman Singh
Angel
|
1 | Singapore | Series A | Life Science, Biotechnology | |
|
Kuldeep Rajput
Angel
|
1 | Singapore | Series A | Life Science, Biotechnology | |
|
Johannes Hille
Angel
|
1 | Singapore | Seed | Medical, Health Care, Biotechnology | |
|
Kane Black
Angel
|
1 | Angel | |||
|
Chang Kim
Angel
|
1 | United States | Pre-Seed, Seed, Series A | Gaming, Ad Network, Loyalty Programs | $1.3M–$2.8M |
|
Leo Lozner
Angel
|
1 | Singapore, United States | Angel, Series A | Sports, Fitness, Genetics | |
|
Idgar Van Kippersluis
Angel
|
1 | Singapore | Seed | AgTech, Agriculture, Animal Feed | |
|
Eric Urhane
Angel
|
1 | United States, Mexico, Singapore | Seed, Angel | Software, Health Care, Biotechnology | $1.1M–$1.9M |
|
Jeffrey Tiong
Angel
|
1 | Singapore | Pre-Seed, Seed | Health Care, Information Technology, Artificial Intelligence | $738k–$4M |
|
Siu Quek
Angel
|
1 | Singapore, Indonesia | Seed, Pre-Seed, Series A | Health Care, Education, Information Technology | $260k–$7.6M |
|
Matt Cutts
Angel
|
1 | United States, Canada, Mexico | Seed, Angel, Series A | SaaS, Health Care, Medical | $493k–$2.8M |
|
Feng Hu
Angel
|
1 | United States, India, Singapore | Seed, Pre-Seed, Convertible Note | Communities, Mobile Apps, CRM | $1.3M–$1.4M |
|
Roy Oron
Angel
|
1 | United States, Israel, Singapore | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Mobile | $700k–$1.5M |
|
Nadav Rosenberg
Angel
|
1 | United Kingdom, France, Israel | Seed, Pre-Seed, Series A | Software, Biotechnology, Artificial Intelligence | $850k–$21M |
|
Benjamin Boyer
Angel
|
1 | United States, China, Singapore | Series C, Seed, Series B | Software, Internet, E-Commerce | $1.2M–$110M |
|
Bud Biswas
Angel
|
1 | Singapore | Seed | Health Care, Biotechnology, Health Diagnostics | |
|
Evan DiMeglio
Angel
|
1 | United States, Canada, Singapore | Seed, Pre-Seed, Series B | Software, E-Commerce, Gaming | $3.2M–$4M |
|
Xiangliang Lin
Angel
|
1 | Singapore, United Kingdom | Seed | Medical, Biopharma, Health Care | |
|
Y S Shashidhar
Angel
|
1 | Singapore | Seed | Health Care, Biotechnology, Health Diagnostics | |
|
Alice Foo
Angel
|
1 | Singapore | Pre-Seed | Recycling, Biotechnology, Waste Management | |
|
Ravindran Govindan
Angel
|
1 | Singapore | Seed | Health Care, Biotechnology, Health Diagnostics | |
|
Jack Wang
Angel
|
1 | Singapore | Seed | Fertility, Biotechnology, Medical Device | |
|
Ron Sim
Angel
|
1 | Singapore | Series A | Beauty, Fitness, Genetics | |
| Access all 36 angel investors in Singapore Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Tak Wai CHUNG joined EQT Partners in February 2009 as a Vice President.Tak Wai holds a Bachelor of Arts degree in Molecular Biology and Biochemistry and Mathematics-Economics from Wesleyan University (High Honors, Phi Beta Kappa), and a Master of Business Administration degree from the Tuck School of Business at Dartmouth.Prior to joiningEQT Partners, Tak Wai was with Lehman Brothers for over six years. While at Private Equity in Hong Kong, he focused on making direct investments into China. Before that, he was in the Investment Banking division covering primarily telecommunications, financial institutions and natural resources in both New York and Hong Kong.Tak Wai is a member of the Mid Market Partners Investment Committee and the Greater China II Internal Investment Committee.
Show more...Investment focus
- Industry: Food Processing, Waste Management
- Stage:Seed, Angel
- Geography: Singapore
Investor stats
- Total investments: 2
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Ento Industries — At ENTO INDUSTRIES, food waste is given a new lease of life. Our focus as a biotechnology company is to close the loop on food waste with the help of our army of Black Soldier Flies.
Paul Buchheit is based out of Mountain View, California and is the Co-Founder and General Partner of Standard Capital. Paul Buchheit attended Case Western Reserve University.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, E-Commerce
- Stage:Seed, Series A, Angel
- Geography: United States, Canada, India
Investor stats
- Total investments: 153
- Round size: Seed $1.1M–$5M; Angel $100k–$1.6M; Series A $2.5M–$14M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- SiPhox Health — Painless, 5-minute biomarker testing at home. Clear insights, trend tracking, and a personalized plan built around your results.
- BuildForever — BuildForever build products that feel personal, magical and deeply human.
- Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Te-Ling Nai is an individual investor.
Show more...Investment focus
- Industry: Food Processing, Waste Management
- Stage:Seed, Angel
- Geography: Singapore
Investor stats
- Total investments: 2
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Ento Industries — At ENTO INDUSTRIES, food waste is given a new lease of life. Our focus as a biotechnology company is to close the loop on food waste with the help of our army of Black Soldier Flies.
Frederik Vandermarlie
Show more...Investment focus
- Industry: Medical, Legal Tech, Health Care
- Stage:Seed
- Geography: Belgium, Singapore
Investor stats
- Total investments: 2
- Round size: Seed $2.3M–$4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- X-ZELL — Early, pain-free cancer cell detection
- Henchman — Effortlessly find the clauses you’re looking for by applying our AI to your existing contracts.
Gireesh Narsimhan
Show more...Investment focus
- Industry: Health Care, Biotechnology, Health Diagnostics
- Stage:Seed
- Geography: Singapore
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Cardiotrack — Cardiotrack makes preventive health screening seamless by combining at-home convenience with advanced AgenticAI-driven automation on Ethos.AI platform.
John Ballantyne is a founder of Agathos Biologics. He co-founded Aldevron with Michael Chambers in 1998 and has been the Chief Scientific Officer since its establishment. His innovative work at Aldevron includes creation of the GMP Source product line and collaborative research with military scientists in the development of vaccine andpassive-based countermeasures to lethal and potentially weaponized viral hemorrhagic threats such as Ebola, Marburg and some hantavirus family members. He leads the research and development team at Aldevron which develops new methods and products through internal programs, collaborations, and technology licensing. John sees the advances in biotechnology providing opportunities for Agathos to enable ethical pharmaceutical development that will benefit patients, employees, and society. Ballantyne received undergraduate degrees in Pharmacy from the Central Institute of Technology and the University of Otago in New Zealand. After beginning graduate school in New Zealand he transferred to the United States in 1994 and completed his Ph.D. in Pharmaceutical Sciences at North Dakota State University.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Seed, Series A, Angel
- Geography: United States, Singapore
Investor stats
- Total investments: 11
- Round size: Seed $4.5M–$7M; Series A $12M–$30M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
- SmartWorx — Enterprise no-code platform. Build governed, AI-powered enterprise applications without writing a single line of code. Not bolted on. Built in.
- GlucoTrack — GlucoTrack is a medical device manufacturing company that specializes in developing a non-invasive glucose monitoring devices. It has developed a medical device that measures glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic.
Co-founder & Chief Privacy Officer @ Biofourmis
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Series A
- Geography: Singapore
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Neuroglee Therapeutics — Providing immediate access to clinically proven, comprehensive memory and dementia care and support for care partners that improves experience, outcomes and costs.
Investment focus
- Industry: Life Science, Biotechnology
- Stage:Series A
- Geography: Singapore
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Neuroglee Therapeutics — Providing immediate access to clinically proven, comprehensive memory and dementia care and support for care partners that improves experience, outcomes and costs.
Founder & CEO @ Biofourmis
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Series A
- Geography: Singapore
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Neuroglee Therapeutics — Providing immediate access to clinically proven, comprehensive memory and dementia care and support for care partners that improves experience, outcomes and costs.
Johannes Hille
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Singapore
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!A seasoned technology entrepreneur, with an extensive and diverse international career in senior and executive leadership across the technology, biotechnology, medical device and healthcare investment sectors globally.Mr. Black began his career with Tokyo Stock Exchange (Jasdaq) listed semiconductor trading company Adtec Corporation K.K (nowknown as AKIBA Holdings (6840:Tokyo) becoming Director and Head of Operations for Europe, based in London U.K. In 2005 he was instrumental in the takeover of Adtec Corporation by Japanese technology company Shinden Hightex Corporation (3131:Tokyo) and remained a Director with the company, based in London.In 2012 he co – founded Nova Satra Health to leverage the latest developments in medical technologies with a view to developing, collaborating and commercialising these cutting-edge therapies across the med tech spectrum. This led, in 2014, to the establishment of Singapore based molecular diagnostic developer Nova Satra Dx Pte Ltd.In August 2019 Nova Satra Dx merged with another women’s health focused molecular diagnostics developer, INEX Innovations Exchange in a US$72 Million deal - creating INEX Innovate.In 2020 Mr. Black was invited to sit as Council Member of the National University of Singapore's, NUS Medicine International Council and in 2022 was selected as EY Singapore Entrepreneur of the Year - Biotechnology
Show more...Investment focus
- Stage:Angel
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Nova Satra Dx — Nova Satra Dx is a molecular diagnostics company headquartered in Singapore. The company is committed to empowering patients and physicians through the research, development and commercialisation of novel blood based diagnostic tests. These tests provide rapid and accurate detection of cancer using Asian-specific epigenetic biomarkers. Based onits clinically validated NovoTect™ technology developed by the University of Oxford, Nova Satra’s diagnostic tests can detect and identify changes in gene expression which are linked to cancer. The company is developing a pipeline of tests for breast, colon, prostate, stomach and lung cancers. For more information, please visit www.novasatra.com
Chang Kim is the CEO of Tapas Media.
Show more...Investment focus
- Industry: Gaming, Ad Network, Loyalty Programs
- Stage:Pre-Seed, Seed, Series A
- Geography: United States
Investor stats
- Total investments: 4
- Round size: Pre-Seed $1.3M–$2.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Luckmon — Luckmon Mobile Games Website Let's Play our games and collect gift card.
- Noah's Farm — Noah's Farm is an AI-based flavor factor developer that leverages advanced machine learning algorithms and data-driven sensory analysis to discover, design, and optimize novel flavor compounds, enabling food and beverage companies to create unique, consistent, and consumer-preferred taste experiences more efficiently and sustainably.
- The Data Foundation — Story is AI-native infrastructure for the intellectual property economy.
Investment focus
- Industry: Sports, Fitness, Genetics
- Stage:Angel, Series A
- Geography: Singapore, United States
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Gero — Utilizing whole-exome sequencing data for in-human AI drug discovery
- Zenia — Thanks to Zenia, yoga beginners now have easier and more affordable access to dive into yoga at home and practice with all the information they need. We believe nothing looks as good as healthy feels.Safety first. We’ve built Zenia to be a guide that adapts to your pace, monitors the progress, and gives gentle corrections. Whether you want tostart yoga, build strength, get in shape, feel better, or be inspired, the app will help you to achieve your goals.Easy. Safe yoga practice doesn’t need to happen at an offline yoga studio. You can access the Zenia studio online from the comfort of your home and, while you’re at it, get instant feedback from your teacher.
Distinguished Fellow @ INSEAD Distinguished Fellow @ INSEAD
Show more...Investment focus
- Industry: AgTech, Agriculture, Animal Feed
- Stage:Seed
- Geography: Singapore
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- INSEACT — Biotech company producing protein from black soldier fly insects
Eric Urhane
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Angel
- Geography: United States, Mexico, Singapore
Investor stats
- Total investments: 5
- Round size: Seed $1.1M–$1.9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
- X-ZELL — Early, pain-free cancer cell detection
- Chirply — Chirply is a platform for crowd-sourcing & crowd-curating design. Chirply's mission is to build engagement, stickiness, and virality through crowd-sourcing design. Initially the company focused on the launch of a marketplace for crowd-sourced design for paper goods - an industry that hasn't been disrupted since the advent of theprinting press. Chirply then launched a B2B platform for crowd-sourced design for brands to help engage users and use design to make daily products inspiring.
Jeffrey Tiong is the Founder & CEO of PatSnap. Jeffrey Tiong attended the National University of Singapore. Jeffrey Tiong has received the IT Leader Award 2019 SCS and EY Entrepreneur of the year 2018 Singapore.
Show more...Investment focus
- Industry: Health Care, Information Technology, Artificial Intelligence
- Stage:Pre-Seed, Seed
- Geography: Singapore
Investor stats
- Total investments: 4
- Round size: Pre-Seed $738k–$4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Formas.AI — The Best AI Orchestrator for Architecture, Interior Design & Spatial Planning. Sketch to Image, Instant Video Narratives, 3D Rendering, Vibe Architecture.
- Mito Health — An AI-Powered medical team dedicated to optimising your health. Focusing on in-depth diagnostics and evidence-based strategies across 5 key pillars of nutrition, sleep, exercise, supplements and mental well-being.
- StratifiCare — At StratifiCare, we focus on the development and manufacturing of IVD (In-Vitro Diagnostics) assay solutions for personalized medicine. With more than 50 years of cumulative in-depth experience in Biomedical R&D and technology commercialization, StratifiCare strives to empower personalised medicine.
Siu Rui Quek is the Co-founder and CEO of Carousell. Siu Rui previously worked at VSee as a Collaboration Evangelist. Siu Rui Quek attended the National University of Singapore. Siu Rui Quek has received the Asia's Most Influential Award, Outstanding Young Alumni Award, and Eminent Business Alumni Award.
Show more...Investment focus
- Industry: Health Care, Education, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Singapore, Indonesia
Investor stats
- Total investments: 14
- Round size: Seed $743k–$7.6M; Pre-Seed $260k–$1.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Yolk.fm — Yolk.fm is a social platform that allows users to chat rather than send text messages.
- Evo — Social Commerce Software
- Circular — We are making subscriptions the best way to experience tech. Circular aims to accelerate the circular economy and maximise the useful lives of each tech device to its fullest potential.
Matt Cutts joined Google as a Software Engineer in January 2000. Before Google, he was working on his Ph.D. in computer graphics at the University of North Carolina at Chapel Hill. He has an M.S. from UNC-Chapel Hill, and B.S. degrees in both mathematics and computer science from the University of Kentucky.Matt wrote SafeSearch, which isGoogle's family filter. In addition to his experience at Google, Matt held a top-secret clearance while working for the Department of Defense, and he's also worked at a game engine company. He claims that Google is the most fun by far.Matt talks about webmaster-related issues on his
Show more...Investment focus
- Industry: SaaS, Health Care, Medical
- Stage:Seed, Angel, Series A
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 11
- Round size: Seed $493k–$2.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
- X-ZELL — Early, pain-free cancer cell detection
- Meter Feeder — Easily pay for parking through MeterFeeder
Feng Hu
Show more...Investment focus
- Industry: Communities, Mobile Apps, CRM
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: United States, India, Singapore
Investor stats
- Total investments: 5
- Round size: Seed $1.3M–$1.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Credy — Credy provides instant online loan at low interest rate. Apply now for personal loan, education loan, medical loan, credit refinancing or other loans.
- DIVE - Dating With Games — DIVE-Dating With Gaming is a trendy dating and gaming app. It offers super interesting roleplay games that break the ice and that lead to deeper and more fun experiences between matches.
- Audetemi Inc. — Audetemi makes it easy for enterprises to enable their business on mobile, and create a superior, and engaging customer experience. Audetemi One platform allows businesses to effectively engage their customers by seamlessly integrating traditional customer engagement platforms onto their smartphones.
Roy Oron is an early stage Tech/Biotech investor as well as the founder and general partner at ITI Venture Capital Partners.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Mobile
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Israel, Singapore
Investor stats
- Total investments: 20
- Round size: Seed $700k–$1.5M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- 4M Analytics — 4M Analytics' unique Technology provides owners, consulting engineers, and contractors a complete, accurate, and up-to-date subsurface-infrastructure database.
- Atlas Invest — Commercial real estate bridge loans up to $20M with same-day term sheets and funding in as few as 7 days. Institutional private credit for investors.
- EdiTy Therapeutics — EdiTy Therapeutics is a biotechnology company that develops a gene-editing technology designed for in-vivo gene-editing of target cells. It utilizes T-cells machinery to directly deliver gene-editing agents to target cells in-vivo. Yoav Manaster established the Ness Ziona, HaMerkaz, Israel-based company in 2020.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.
Show more...Investment focus
- Industry: Software, Biotechnology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, France, Israel
Investor stats
- Total investments: 15
- Round size: Seed $850k–$3.1M; Pre-Seed $2M–$2M; Series A $18M–$21M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Teora — Crude oil derived products have infiltrated every industry – synthetic colors, flavors, fragrances in food, dyes in textiles, fertilizers and packaging material that harm humans and the planet. TeOra’s mission is to replace synthetics with naturals that are manufactured in a sustainable and predictable manner. A microorganism is the best factory,optimized over billions of years of evolution and TeOra designs it to produce desired products. Using microfluidics and AI, TeOra offers 100 times faster and cheaper design of smart micro-organisms in weeks to months instead of years.
- thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
- Lindus — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
Ben Boyer is a Managing Director of Tenaya Capital, and he has been a member of the Tenaya investment team since 2000.Previously, Ben was a member of Lehman Brothers' Technology Investment Banking group, where he was responsible for corporate finance and strategic advisory assignments.Ben holds an M.B.A. from Stanford Graduate Schoolof Business and a B.S. in human and organizational development from Vanderbilt University.
Show more...Investment focus
- Industry: Software, Internet, E-Commerce
- Stage:Series C, Seed, Series B
- Geography: United States, China, Singapore
Investor stats
- Total investments: 22
- Round size: Seed $1.2M–$4.4M; Series B $12M–$50M; Series C $10M–$110M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Kangaroo — No hidden upfront costs or astronomical monthly monitoring fees. Our plans are contract-free, flexible and affordable. We even help you earn cash back on your insurance policy! Our sensors are batteries-included, peel-and-stick, app-controlled easy. Choose a free plan or professionally monitored plan for only $99/yr.
- People.ai — Uncover the Fastest Path to Revenue
- Triparound — All-in-one guest experience software for hotels and vacation rentals. Reduce admin time, streamline bookings, and grow ancillary revenue.
Bud has an impressive track record of starting networking companies and turning them into profitable businesses, and has over twenty years of industry experience in the field of high speed networking, in both technical and managerial positions. He founded Digital Technology, which was acquired by Agilent Technologies in the year 2000. He was alsoone of the founding partners of Network Software, a networking consulting company, and CCS, one of the first portable PC companies of the early 80's. Bud has an MS in Electrical Engineering and an MS in Computer Science from Ann Arbor, Michigan.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Health Diagnostics
- Stage:Seed
- Geography: Singapore
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cardiotrack — Cardiotrack makes preventive health screening seamless by combining at-home convenience with advanced AgenticAI-driven automation on Ethos.AI platform.
Evan DiMeglio
Show more...Investment focus
- Industry: Software, E-Commerce, Gaming
- Stage:Seed, Pre-Seed, Series B
- Geography: United States, Canada, Singapore
Investor stats
- Total investments: 5
- Round size: Seed $3.2M–$4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cyble — Cyble is a leading threat intelligence provider that obtains and processes data from the dark web and OSINT to mitigate external cybersecurity risks
- TurtleTree — TurtleTree produces the world's first sustainable lactoferrin LF+ using precision fermentation. Animal-free, vegan-certified for food, beverages & supplements.
- Triumph — Triumpharcade home page description
Xiangliang Lin
Show more...Investment focus
- Industry: Medical, Biopharma, Health Care
- Stage:Seed
- Geography: Singapore, United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MFX — MFX develops microfluidic-based platforms for cell and gene therapy development and manufacturing
- ImpacFat — ImpacFat is a food production company that develops fish meat alternatives through cell cultivation.
Y S Shashidhar
Show more...Investment focus
- Industry: Health Care, Biotechnology, Health Diagnostics
- Stage:Seed
- Geography: Singapore
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cardiotrack — Cardiotrack makes preventive health screening seamless by combining at-home convenience with advanced AgenticAI-driven automation on Ethos.AI platform.
Alice Foo is an angel investor for Alterpacks.
Show more...Investment focus
- Industry: Recycling, Biotechnology, Waste Management
- Stage:Pre-Seed
- Geography: Singapore
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AlterPacks — Alterpacks - New Materials Solutions. A Singapore Management University, Institute of Innovation & Entrepreneurship, Business Innovation Generator (BIG) Incubatee.
Ravindran Govindan - Executive Chairman and founder @ Eight Mercatus
Show more...Investment focus
- Industry: Health Care, Biotechnology, Health Diagnostics
- Stage:Seed
- Geography: Singapore
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cardiotrack — Cardiotrack makes preventive health screening seamless by combining at-home convenience with advanced AgenticAI-driven automation on Ethos.AI platform.
Jack Wang
Show more...Investment focus
- Industry: Fertility, Biotechnology, Medical Device
- Stage:Seed
- Geography: Singapore
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Hannah Life Technologies — We make Earth's best products and services for couples in their parenthood journey.
Ron Sim
Show more...Investment focus
- Industry: Beauty, Fitness, Genetics
- Stage:Series A
- Geography: Singapore
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Imagene Labs — Imagene Labs Pte Ltd empowers consumers to optimise their health by providing customised wellness and lifestyle solutions tailored to their unique DNA profiles. Led by medical doctors and scientists, the company provides an entire ecosystem of genomics-based solutions ranging from wellness DNA tests, personalised lifestyle recommendations, bespokeskin serums and nutritional supplements, and mobile health apps that help people live, look and feel their best.
Biotech Angel investor funding in Singapore at a glance
Stats across 27 deals from 36 investors.
Access all 36 angel investors in Singapore Biotech startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech Angel Investors in Singapore investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 36 angel investors investing in Singapore Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!